Oregon Health & Science University

Essais liés22clinical trials

VillePortlandlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05386108

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
BrioVAD System	Insuffisance cardiaque	Non applicable	NCT06310031	INNOVATE — Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure	ACTIVE_NOT_RECRUITING
anito-cel	Myasthénie	Phase 1	NCT06626919	Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases	RECRUITING
Investigational PFO Closure Device	Accident vasculaire cérébral	Non applicable	NCT05069558	OCCLUFLEX — Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion	ACTIVE_NOT_RECRUITING
Acoramidis	Alzheimer	Phase 2	NCT03536767	Open-Label Study of AG10 in Patients With Cardiomyopathy	TERMINATED
Elacestrant	Cancer	Phase 1/2	NCT05386108	ELECTRA — Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer	RECRUITING
Intervention 1	Épilepsie	Non applicable	NCT07803692	HIFU for MRGE — High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy in Patients Ages 18 Years to 89 Years	NOT_YET_RECRUITING
ONO-2020	Alzheimer	Phase 2	NCT06881836	A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease	COMPLETED
Aerobic Exercise for Remyelination in Multiple Sclerosis	SEP	Phase 1/2	NCT04539002	Aerobic Exercise for Remyelination in Multiple Sclerosis	COMPLETED
EXV-802	Alzheimer	Phase 2/3	NCT07284472	SERENADA — Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia	RECRUITING
Neuraceq	Alzheimer	À vérifier	NCT05617014	ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4	ENROLLING_BY_INVITATION
JZP926 capsule	Épilepsie	Phase 2/3	NCT07723963	A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy	NOT_YET_RECRUITING
Acoramidis	Alzheimer	Phase 3	NCT06563895	Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	RECRUITING
Adalimumab	Parkinson	Phase 2	NCT06996652	PRISMS — An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)	RECRUITING
Standard lymphodepletion regimen	Myasthénie	Phase 2/3	NCT06193889	KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis	RECRUITING
CABA-201	Myasthénie	Phase 1/2	NCT06359041	RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis	RECRUITING
RGX-202	Myopathies	Phase 2/3	NCT05693142	AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)	ACTIVE_NOT_RECRUITING
ASP2957	Myopathies	Phase 1/2	NCT07052929	Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators	RECRUITING
CT1812	Alzheimer	Phase 2	NCT05531656	A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease	ACTIVE_NOT_RECRUITING
Anti-hypertensive therapy	Hypertension	Phase 4	NCT02299414	Chronic Hypertension and Pregnancy (CHAP) Project	COMPLETED
Descartes-08	Myasthénie	Phase 2	NCT04146051	Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)	ACTIVE_NOT_RECRUITING
Alpha Lipoic Acid	SEP	Phase 1	NCT03493841	Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis	COMPLETED
RNS® System	Épilepsie	Phase 4	NCT00572195	RNS® System LTT Study	COMPLETED